PubMed:31138793 / 795-961 JSONTXT

{"project":"PubMed_ArguminSci","denotations":[{"id":"T7","span":{"begin":0,"end":166},"obj":"DRI_Background"}],"text":"In malignant melanoma models, acute genetic blockade of BCL10 signaling selectively in Tregs or pharmacological MALT1 inhibition enhances anti-tumor immune responses."}

{"project":"GoldHamster","denotations":[{"id":"T103","span":{"begin":3,"end":21},"obj":"D008545"},{"id":"T104","span":{"begin":3,"end":21},"obj":"D008545"},{"id":"T107","span":{"begin":56,"end":61},"obj":"PR:Q9Z0H7"},{"id":"T108","span":{"begin":56,"end":61},"obj":"PR:000004689"},{"id":"T109","span":{"begin":56,"end":61},"obj":"Q9QYN5"},{"id":"T110","span":{"begin":56,"end":61},"obj":"PR:O95999"},{"id":"T111","span":{"begin":56,"end":61},"obj":"Q9Z0H7"},{"id":"T112","span":{"begin":56,"end":61},"obj":"O95999"},{"id":"T113","span":{"begin":56,"end":61},"obj":"PR:Q9QYN5"},{"id":"T114","span":{"begin":62,"end":71},"obj":"GO:0023052"},{"id":"T117","span":{"begin":112,"end":116},"obj":"UBERON:0001961"},{"id":"T118","span":{"begin":112,"end":117},"obj":"PR:Q9UDY8"},{"id":"T119","span":{"begin":112,"end":117},"obj":"PR:Q2TBA3"},{"id":"T120","span":{"begin":112,"end":117},"obj":"PR:000010096"},{"id":"T121","span":{"begin":143,"end":148},"obj":"D009369"},{"id":"T122","span":{"begin":143,"end":148},"obj":"D009369"}],"text":"In malignant melanoma models, acute genetic blockade of BCL10 signaling selectively in Tregs or pharmacological MALT1 inhibition enhances anti-tumor immune responses."}

{"project":"GlyCosmos15-HP","denotations":[{"id":"T1","span":{"begin":3,"end":21},"obj":"Phenotype"},{"id":"T2","span":{"begin":143,"end":148},"obj":"Phenotype"}],"attributes":[{"id":"A1","pred":"hp_id","subj":"T1","obj":"HP:0002861"},{"id":"A2","pred":"hp_id","subj":"T2","obj":"HP:0002664"}],"namespaces":[{"prefix":"HP","uri":"http://purl.obolibrary.org/obo/HP_"}],"text":"In malignant melanoma models, acute genetic blockade of BCL10 signaling selectively in Tregs or pharmacological MALT1 inhibition enhances anti-tumor immune responses."}

{"project":"mondo_disease","denotations":[{"id":"T2","span":{"begin":3,"end":21},"obj":"Disease"},{"id":"T3","span":{"begin":143,"end":148},"obj":"Disease"}],"attributes":[{"id":"A2","pred":"mondo_id","subj":"T2","obj":"http://purl.obolibrary.org/obo/MONDO_0005105"},{"id":"A3","pred":"mondo_id","subj":"T3","obj":"http://purl.obolibrary.org/obo/MONDO_0005070"}],"text":"In malignant melanoma models, acute genetic blockade of BCL10 signaling selectively in Tregs or pharmacological MALT1 inhibition enhances anti-tumor immune responses."}